Nagatsu T, Ichinose H
Institute for Comprehensive Medical Science, School of Medicine, Fujita Health University, Aichi, Japan.
J Neural Transm Suppl. 1997;49:203-9.
GTP cyclohydrolase I is the rate-limiting enzyme for the biosynthesis of tetrahydrobiopterin, which is the cofactor for tyrosine hydroxylase, the rate-limiting enzyme for dopamine biosynthesis. We found that dominantly inherited, hereditary progressive dystonia (HPD), first described by Segawa and also called dopa responsive dystonia (DRD), is caused by the mutations of GTP cyclohydrolase I gene, the partial decrease in the enzyme activity, and probably in striatal dopamine level, to less than 20% of the normal values. Juvenile parkinsonism and Parkinson's disease are also striatal dopamine deficiency, but no mutation in the enzyme has not been found, and they are supposed to be different from HPD/DRD in which no cell death of the nigrostriatal dopamine neurons occurs.
GTP环化水解酶I是四氢生物蝶呤生物合成的限速酶,四氢生物蝶呤是酪氨酸羟化酶的辅因子,而酪氨酸羟化酶是多巴胺生物合成的限速酶。我们发现,由Segawa首次描述的、也被称为多巴反应性肌张力障碍(DRD)的显性遗传性进行性肌张力障碍(HPD),是由GTP环化水解酶I基因突变、酶活性部分降低以及纹状体多巴胺水平可能降至正常值的20%以下所致。青少年帕金森病和帕金森病也存在纹状体多巴胺缺乏,但未发现该酶有突变,它们被认为与HPD/DRD不同,后者黑质纹状体多巴胺神经元无细胞死亡。